Home Search

OXIS - search results

If you're not happy with the results, please do another search
marijuana stock news

GT Biopharma, Inc. (OXISD) Welcomes Thomas N. Chase, MD

Thomas N. Chase, MD, Joins GT Biopharma, Inc. as an Advisor to the Board GT Biopharma, Inc. (OXISD), a targeted immunotherapies company with close to...
marijuana stocks news

GT Biopharma (OXISD) Announces Development Plan For Non-Opioid Neuropathic Pain Treatment “PainBrake”

LOS ANGELES, CA / ACCESSWIRE / September 11, 2017 / GT Biopharma Inc. announced today that it has made the required payment to license...
marijuana stock news

GT Biopharma (OXISD) Hires Former Pfizer CMO/Vice President and Senior Director of Oncology Research...

LOS ANGELES, CA / ACCESSWIRE / September 7, 2017 / GT Biopharma Inc. (OXISD) announced today the appointment of Dr. Raymond Urbanski, the former...
marijuana stocks news

GT Biopharma Inc. (OXISD) Announces Reverse Stock Spilt As Part of Planned Merger

GT Biopharma, Inc. Announces Reverse Stock Spilt As Part of Oxis-Georgetown Planned Merger GT Biopharma Inc. (formerly known as Oxis International, Inc.) announced today a...
marijuana_stocks_conference_call

GT Biopharma (OXIS) Conf Call Reminder

GT Biopharma (OXIS) Conf. Call Today GT Biopharma (OXIS) made another move higher on Today (8-16) to highs of $0.123. This marks a total run...
marijuana stocks news

GT Biopharma Inc. (OXIS) Executives to Present at Rodman & Renshaw Conference in New...

GT Biopharma (OXIS) Executives to Present at Rodman & Renshaw Conference in New York  GT Biopharma Inc. (OTCQB:OXIS and Euronext Paris OXI.PA) announced today that...
marijuana stocks chart

Re-Cap & Update on GT Biopharma (OXIS)

For the last week, we’ve been covering a company that has seen a huge bump in attention and trading momentum.  GT Biopharma (OXIS) could be...
marijuana stocks news

GT Biopharma Inc. (OXIS) Announces Corporate Update Conference Call

GT Biopharma, Inc. (Oxis) Announces Corporate Update Conference Call With Incoming CEO Dr. Kathleen Clarence-Smith and Chairman Anthony Cataldo GT Biopharma Inc. (OTCQB:OXIS and Euronext...
marijuana stocks news

GT Biopharma Inc. (OXIS) Announces Enrollment of Fourth Patient in FDA Phase 2 Trial

GT Biopharma (OXIS) Announces Enrollment of Fourth Patient in FDA Phase 2 Trial of Cancer Drug OXS-1550  GT Biopharma Inc. (OTCQB: OXIS) and Euronext Paris...
marijuana stocks news

$OXIS Adds New Patients in Phase 1/Phase 2 Clinical Trials

Oxis Adds New Patients in Phase 1/Phase 2 Clinical Trial of Key Cancer Drug OXS-1550  Oxis International Inc. (OTC:OXIS and OXI.PA), a biotechnology company focused...

Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Marijuana Stocks, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com